Generic versions of enoxaparin available for clinical use in Brazil are similar to the original drug

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 7, 2011, Pages 1419-1422

  Glauser, B F ^a,b   Vairo, B C ^a,b   Oliveira, C P M ^a,b   Cinelli, L P ^c   Pereira, M S ^a   Mourao P A S ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto de Bioquímica Médica   (Brazil)

^c Instituto Macaé de Metrologia e Tecnologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; BLOOD CLOTTING; BRAZIL; CHINA; GEL PERMEATION CHROMATOGRAPHY; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; HYDROLYSIS; INDIA; LETTER; LIGHT ABSORPTION; MOLECULAR SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTICOAGULANTS; BRAZIL; DRUGS, GENERIC; ENOXAPARIN; HEMORRHAGE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; RATS; THROMBOSIS;

EID: 79959817995     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04330.x     Document Type: Letter

References (7)

1. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-98.
2. Harenberg J, Kakkar A, Bergqvist D, Barrowcliffe T, Casu B, Fareed J, Mismetti P, Ofosu FA, Raake W, Samama M, Schulman S. Recommendations on biosimilar low-molecular-weight-heparins. J Thromb Haemost 2009; 7: 1222-5.
3. Gray E, Mulloy B. Biosimilar low-molecular-weight heparin products. J Thromb Haemost 2009; 7: 1218-21.
4. Fareed J, Leong WL, Hoppensteadt DA, Jeske WP, Walenga J, Wahi R, Bick RL. Generic low-molecular-weight heparins: some practical considerations. Semin Thromb Hemost 2004; 30: 703-13.
5. Aquino RS, Pereira MS, Vairo BC, Cinelli LP, Santos GRC, Fonseca RJC, Mourão PAS. Heparins from porcine and bovine intestinal mucosa: are they similar drugs? Thromb Haemost 2010; 103: 1005-15.
6. Guerrini M, Gugliere S, Naggi A, Sasisekharam R, Torri G. Low- molecular-weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost 2007; 33: 478-87.
7. Jeske WP, Walenga JM, Hoppensteadt DA, Vandenberg C, Brubaker A, Adiguzel C, Bakhos M, Fareed J. Differentiating low-molecular-weight heparins based on chemical, biological and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins. Semin Thromb Hemost 2008; 34: 74-85.